KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Cash & Equivalents (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 10.04%
Dec 28, 2025 8.11%
Sep 28, 2025 -1.86%
Jun 29, 2025 -51.72%
Mar 30, 2025 59.61%
Dec 29, 2024 20.65%
Sep 29, 2024 -19.69%
Jun 30, 2024 -2.34%
Mar 31, 2024 16.53%
Dec 31, 2023 10.80%
Oct 1, 2023 -6.87%
Jul 2, 2023 10.50%
Apr 2, 2023 48.73%
Jan 1, 2023 13.51%
Oct 2, 2022 3.39%
Jul 3, 2022 4.97%
Apr 3, 2022 -27.78%
Jan 2, 2022 -17.71%
Oct 3, 2021 22.83%
Jul 4, 2021 13.11%
Apr 4, 2021 -9.40%
Jan 3, 2021 -26.26%
Sep 27, 2020 69.72%
Jun 28, 2020 -28.05%
Mar 29, 2020 -10.26%
Dec 29, 2019 6.50%
Sep 29, 2019 13.03%
Jun 30, 2019 -2.43%
Mar 31, 2019 -18.63%
Dec 30, 2018 12.77%
Sep 30, 2018 -8.61%
Jul 1, 2018 20.02%
Apr 1, 2018 -17.87%
Dec 31, 2017 13.38%
Oct 1, 2017 24.79%
Jul 2, 2017 -39.75%
Apr 2, 2017 10.21%
Jan 1, 2017 4.21%
Oct 2, 2016 -2.33%
Jul 3, 2016 34.48%
Apr 3, 2016 0.94%
Jan 3, 2016 0.68%
Sep 27, 2015 28.20%
Jun 28, 2015 -11.25%
Mar 29, 2015 -17.46%
Dec 28, 2014 5.10%
Sep 28, 2014 -2.94%
Jun 29, 2014 -27.82%
Mar 30, 2014 -5.76%
Dec 29, 2013 21.64%
Sep 29, 2013 -0.60%
Jun 30, 2013 16.51%
Mar 31, 2013 -0.38%
Dec 30, 2012 -3.71%
Sep 30, 2012 10.28%
Jul 1, 2012 -53.61%
Apr 1, 2012 23.33%
Jan 1, 2012 57.15%
Oct 2, 2011 4.29%
Jul 3, 2011 -33.02%
Apr 3, 2011 15.51%
Jan 2, 2011 34.99%
Oct 3, 2010 12.78%
Jul 4, 2010 -7.49%
Apr 4, 2010 -13.07%
Jan 3, 2010 33.35%
Sep 27, 2009 1.45%
Jun 28, 2009 -7.17%